According to The Insight Partners – The global laboratory animal model market is on a steady growth trajectory, underpinned by rising demand for biomedical research, expanding pharmaceutical pipelines, and rapid advances in biotechnology. According to a detailed market research report by The Insight Partners, the market is projected to grow at a CAGR of 8.1% from 2025 to 2031, spanning key geographies including North America, Europe, Asia Pacific, and South and Central America.
Understanding the Market Landscape
Laboratory animal models serve as indispensable tools in preclinical research, enabling scientists to study disease mechanisms, test drug candidates, and evaluate the safety and efficacy of new therapies before human trials. The market is segmented by animal type, covering rats, mice, guinea pigs, rabbits, and other species. Among these, mice and rats dominate usage owing to their genetic similarity to humans, short reproductive cycles, and the availability of a wide range of genetically modified strains.
By application, the market is broadly divided into drug discovery and development, and basic research. Drug discovery and development commands the larger share, driven by continuous investment from pharmaceutical and biotechnology companies seeking to advance novel therapeutics. By end user, pharma and biotech companies lead consumption, followed closely by academic research institutes that rely on animal models for fundamental scientific inquiry.
Get Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00025691
Key Growth Drivers
Three primary factors are fueling market expansion. First, the increasing intensity of drug discovery and development activity is generating sustained demand. As pharmaceutical and biotech firms continue to pursue treatments for oncology, neurology, immunology, and infectious diseases, laboratory animal models remain central to validating therapeutic hypotheses and meeting regulatory requirements for preclinical testing.
Second, the growing global prevalence of chronic diseases such as cancer, diabetes, cardiovascular conditions, and neurological disorders is intensifying research efforts. Animal models are critical for understanding how these diseases progress and for identifying viable drug targets, making them indispensable in the fight against long-term health challenges.
Third, advances in biotechnology and personalized medicine are creating new and more specialized demands. Innovations in gene editing, particularly CRISPR technology, have dramatically increased the use of genetically modified animal models. These models allow researchers to examine the precise role of individual genes in disease development and treatment response, enabling more targeted and predictive research outcomes.
Get Full Copy of This Report @ https://www.theinsightpartners.com/buy/TIPRE00025691
Future Trends Shaping the Market
The laboratory animal model market is also being shaped by important evolving trends. Growing ethical awareness and regulatory pressure are accelerating interest in alternative testing methods, including organ-on-a-chip technologies, 3D cell cultures, and in silico modeling. While these alternatives will not fully replace animal models in the near term, they are prompting the industry to innovate and adopt more humane and sustainable research practices.
Simultaneously, genetically modified animal models are becoming more prevalent as CRISPR and other gene editing tools become increasingly accessible. Knockout and transgenic animal models are now widely used to investigate specific genetic pathways, offering researchers greater precision and reproducibility in experimental outcomes.
Another notable trend is the growing outsourcing of preclinical research to contract research organizations. As pharmaceutical and biotech companies seek to streamline operations and reduce costs, they are increasingly relying on specialized service providers for animal model handling and study management, which in turn drives market demand.
Competitive Landscape
The market features several prominent players, including Charles River Laboratories, Envigo, Eurofins Scientific, genOway, Hera Biolabs, JSR Life Sciences (Crown Bioscience International), Ozgene, PerkinElmer (Horizon Discovery), and Taconic Biosciences. These companies are investing in expanding their model portfolios, enhancing genetic modification capabilities, and broadening their geographic reach.
Top Trending Reports @
Animal Care Services Market Analysis, Regional and Competitive Landscape Forecast by 2031
Laboratory Equipment Services Market Opportunities, Forecast, Size, Analysis till 2031
Laboratory Developed Test Market Size Trends & Key Opportunities 2034
About Us –
The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.
Contact Us:
Contact Person: Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Also Available in : Korean | German | Japanese | French | Chinese | Italian | Spanish